Prognostic and Diagnostic Added Value of Medical Imaging in Staging and Treatment Planning of Gynecological Cancer (PRODIGYN)

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The goal of this observational study is to learn about the added diagnostic and prognostic value of advanced medical imaging procedures in cervical cancer, endometrial cancer and ovarian cancer. The main questions it aims to answer are: * Does advanced medical imaging predict survival? * Can advanced medical imaging improve radiotherapy target planning? * Are advanced medical imaging results associated with risk markers found in tumor tissue? Participants will * Undergo four additional imaging procedures, as compared to clinical routine examinations, two at baseline and two after three months. * Be subject to clinical follow-up for five years.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
View:

• Previously untreated primary cervical, endometrial, or strongly suspected epithelial ovarian cancer.

• Known clinical FIGO stage.

• \>18 years old.

• No other known current or previous malignancy within the last 10 years.

Locations
Other Locations
Sweden
Centre for Gynecology and Obstetrics, Umea University Hospital
RECRUITING
Umeå
Contact Information
Primary
Erika Figaro
erika.figaro@regionvasterbotten.se
+46907850499
Backup
Sara Strandberg, MD, PhD
sara.strandberg@umu.se
+46907850000
Time Frame
Start Date: 2023-05-23
Estimated Completion Date: 2032-05
Participants
Target number of participants: 120
Treatments
Cervix cancer
Newly diagnosed cervix cancer.
Endometrial cancer
Newly diagnosed endometrial cancer.
Ovarian cancer
Strong suspicion of newly diagnosed epithelial ovarian cancer; histopathological confirmation required within 6 months after inclusion.
Sponsors
Leads: Region Västerbotten
Collaborators: Umeå University

This content was sourced from clinicaltrials.gov